Welcome to the real world Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
Increasing the appeal of science Wednesday, August 10, 2005
Although the pharmaceutical industry is viewed as an attractive employer by tomorrow's science graduates, more and more students think a career in science is not sexy enough....(more)
Devolution and the new customers Monday , August 01, 2005
Jonathan Akehurst takes a critical look at how the newly devolved nature of the NHS is forcing pharma companies to reassess their marketing and sales strategies....(more)
Survival of the fittest Monday , August 01, 2005
Evolution or Intelligent Design? Les Rose looks at whether new technology can speed up clinical development, reduce clinical trial costs and bring more drugs to market. ...(more)
